These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents. Ibrahim HS; Abou-Seri SM; Ismail NSM; Elaasser MM; Aly MH; Abdel-Aziz HA Eur J Med Chem; 2016 Jan; 108():415-422. PubMed ID: 26706352 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel (S)-Naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models. Han Mİ; Atalay P; Tunç CÜ; Ünal G; Dayan S; Aydın Ö; Küçükgüzel ŞG Bioorg Med Chem; 2021 May; 37():116097. PubMed ID: 33743356 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors. Şenkardeş S; Han Mİ; Kulabaş N; Abbak M; Çevik Ö; Küçükgüzel İ; Küçükgüzel ŞG Mol Divers; 2020 Aug; 24(3):673-689. PubMed ID: 31302853 [TBL] [Abstract][Full Text] [Related]
7. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling. Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro bioactivity study of new hydrazide-hydrazones of 5-bromo-2-iodobenzoic acid. Popiołek Ł; Patrejko P; Gawrońska-Grzywacz M; Biernasiuk A; Berecka-Rycerz A; Natorska-Chomicka D; Piątkowska-Chmiel I; Gumieniczek A; Dudka J; Wujec M Biomed Pharmacother; 2020 Oct; 130():110526. PubMed ID: 32693180 [TBL] [Abstract][Full Text] [Related]
9. 1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studies. Anichina K; Argirova M; Tzoneva R; Uzunova V; Mavrova A; Vuchev D; Popova-Daskalova G; Fratev F; Guncheva M; Yancheva D Chem Biol Interact; 2021 Aug; 345():109540. PubMed ID: 34139148 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Characterization of a New Benzoindole Derivative with Apoptotic Activity Against Colon Cancer Cells. Hajiaghaalipour F; Faraj FL; Bagheri E; Ali HM; Abdulla MA; Majid NA Curr Pharm Des; 2017; 23(41):6358-6365. PubMed ID: 28325143 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors. Tantak MP; Klingler L; Arun V; Kumar A; Sadana R; Kumar D Eur J Med Chem; 2017 Aug; 136():184-194. PubMed ID: 28494255 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. Kassab AE; Gedawy EM; Hamed MIA; Doghish AS; Hassan RA J Enzyme Inhib Med Chem; 2021 Dec; 36(1):922-939. PubMed ID: 33896327 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones. Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors. Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731 [TBL] [Abstract][Full Text] [Related]
16. Molecular Hybrid Design, Synthesis, In Vitro Cytotoxicity, In Silico ADME and Molecular Docking Studies of New Benzoate Ester-Linked Arylsulfonyl Hydrazones. Ergan E; Çakmak R; Başaran E; Mali SN; Akkoc S; Annadurai S Molecules; 2024 Jul; 29(15):. PubMed ID: 39124882 [TBL] [Abstract][Full Text] [Related]
17. Effect of methanolic extract from silkworm droppings on proliferation and caspase activity in HT-29 human colon cancer cells. Hwang JH; Kim JY; Cha MR; Park HR J Med Food; 2007 Sep; 10(3):467-72. PubMed ID: 17887940 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-naproxen. Han MI; Bekçi H; Uba AI; Yıldırım Y; Karasulu E; Cumaoğlu A; Karasulu HY; Yelekçi K; Yılmaz Ö; Küçükgüzel ŞG Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800365. PubMed ID: 31115928 [TBL] [Abstract][Full Text] [Related]
19. Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation. Eldehna WM; Abo-Ashour MF; Ibrahim HS; Al-Ansary GH; Ghabbour HA; Elaasser MM; Ahmed HYA; Safwat NA J Enzyme Inhib Med Chem; 2018 Dec; 33(1):686-700. PubMed ID: 29560733 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors. Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]